Curious Bioethics: July 31-August 6, 2023
𧫠HeLa cell lawsuit settled; research misconduct & culture; trauma-informed care
In todayâs curated collection, youâll find:
đïžBioethics News: Henrietta Lacksâ suit settled; Postpartum depression pill approved; cyberattacks on hospitals
đRecommended Reading: Grief and poetry; research misconduct & culture
đŠEducational Opportunities: Trauma-informed care & neurobiology
Note: Todayâs news references self-harm and death.
Hey there, Curious Human!
Iâve been enjoying a rare week of peace and quiet at home. My kids are off at Camp Grandma-Grandpa this week, so my partner and I had a weekend with few responsibilities. Thankfully, I could re-arranged my hospital call schedule, and we took a quick trip down the coast to visit our friend Laurel Braitman on her gorgeous avocado and citrus ranch. I learned more about avocado and lemon growing in one weekend than I ever really knew in my whole life. And had amazing conversations. And laughed so damn loud and long. And ate a lot of homemade guacamole. đ„
Yesterday, I facilitated Writing Medicine for a fabulous group of healthcare worker writers. They wrote and shared the most beautiful, lush, deep words. I left with my heart full of hope for a bunch of committed people who want to care for their fellow humans. If you want an excuse to explore your creativity, check out future low-cost writing workshops.
đïž Bioethics in the News
How the âgroundbreakingâ Henrietta Lacks settlement could change research
Thermo Fisher Scientific and Lacksâs family reach a deal over the unethical use of her cells.
Earlier this week, the biotechnology company Thermo Fisher Scientific reached a settlement with the family of Henrietta Lacks, a Black woman who had cells taken from her and used for research without consent more than 70 years ago. The cervical cancer cells, removed during Lacksâs treatment at Johns Hopkins Hospital in Baltimore, Maryland, and known as HeLa cells, were shared widely because of their ability to survive and divide indefinitely in the laboratory â and have led to numerous scientific discoveries. Eventually, they made their way into the hands of companies such as Thermo Fisher in Waltham, Massachusetts, which sells products derived from the cells.
FDA approves first postpartum depression pill in the US
Zuranolone (trade name: Zurzuvae) is the first oral medication approved to treat postpartum depression (PPD). The fast acting 14 days course of once-daily pills can reduce significant barriers to treatment for this serious condition.
Postpartum depression is a major depressive episode occurring later in pregnancy or after birth. PPD is a serious mental health condition impacting up to 1 in every 7 postpartum patients. Data suggests suicide may account for up to 20% of postpartum deaths.
âThe most common side effects include drowsiness, dizziness, diarrhea, fatigue, nasopharyngitis (the common cold), and urinary tract infection. Use of Zurzuvae may cause suicidal thoughts and behavior. Zurzuvae may cause fetal harm. Women should use effective contraception while taking, and for one week after taking, Zurzuvae.â - FDA
Cyberattack causes multiple hospitals to shut emergency rooms and divert ambulances
Prospect Medical Holdings, a private equity healthcare company, endured a system-wide cyberattack, impacting hospitals in California, Connecticut, Pennsylvania, and Rhode Island, and over 160 clinics. While the attack was on the Los Angeles-based company, the cyber network impacted multiple states.
Globally, the healthcare industry continues to be the top target for cyberattacks in the year ending in March, according to IBM's annual report on data breaches. For the 13th straight year, that sector reported the most expensive breaches of any field, averaging $11 million each. That's nearly double the average impact of a breach on the second-largest sector, finance, at $5.9 million each.
The hospitals are unlikely to have networks functioning until next week, leaving clinicians to resort to paper charting.
Data security breaches place patients in serious harm. We are so reliant on digital records that when we switch back to paper, we cannot access patientsâ history, medication records, or other relevant information. We canât click a button to see a patientâs X-rays or laboratory values. There is minimal infrastructure to switch back to a paper system overnight.
When the computers go down, the emergency departments close, diverting patients to other hospitals. This means longer time to emergency care, further increasing harm to patients with serious conditions.
đ Recommended Reading
Ahead of Time
On poetry and mourning
Ninety-three days before she died, my sister sent me a message. Five and a half years earlier, Bita had been diagnosed with stage four intrahepatic cholangiocarcinoma, a rare and deadly form of cancer. She was forty-three. There was a thirteen-centimeter massâroughly the size of a grapefruitâin her liver. When the radiologist friend whoâd helped get Bita into Memorial Sloan Kettering Cancer Center saw me in the hospital corridor after her diagnosis, he burst into tears.
-Kamran Javadizadeh
If youâre looking for more beautiful, long essays to read, I found Kamran Javadizadehâs moving Yale Review essay through Longreads Top 5 Longreads of the Week. Maybe youâll find your next read there too.
Marc Tessier-Lavigneâs resignation shows what happens when you donât pay attention to lab culture
Research ethics is often thought about strictly in terms of personal misconduct, and not often enough in terms of interactions and structures within lab communities that tolerate, and sometimes implicitly promote, corner-cutting and rushing toward publicationâŠ
Think about it this way: If approval and rewards at work are directly linked only to results, not process, where do you put your efforts? When only desired data mean success, and when not producing âthe rightâ data makes you a âloser,â the already fierce pressures are intensified.
đŠEducational Opportunities
No registration is required! Just go straight to YouTube for this on-demand bioethics education.
Trauma-Informed Care and Neurobiology of Trauma
Seattle Childrenâs Dr. Alysha Thompson explains what trauma-informed care is, why itâs important, and how it should fit into our approach to healthcare.
I believe deeply learning and applying trauma-informed practices is the key to healthy, trusting, meaningful relationships with patients. Understanding this framework also empowers us to see the structural factors that traumatize our communities.
          Â
Thatâs it!
As always, thanks for being curious!
Hit reply and let me know what ethics issues you are most curious about this weekâIâd love to hear from you!
See you next week!
Be Well & Be Curious,
Alyssa